
Santen begins European rollout of low-dose atropine for myopia in Germany
Santen is launching low-dose atropine (Ryjunea) in Germany following its approval from the European Commission in June for myopia management. The rollout is an exciting step in the battle against the growing myopia epidemic, which is prevalent across the …